Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 553 results found. Search for [ PB-Jayakumar ]

Results 520 to 540 of 553
PB Jayakumar
October 1, 2015
In 2014, the Office of Manufacturing Quality had given only five warning letters to Indian companies out of a total of 19 issued. At the receiving end last year were firms like Cadila Pharmaceuticals, Marck Biosciences, Sun Pharma, Smruti Organics and USV Limited.


PB Jayakumar
September 25, 2015
Symphony has a 50 per cent share (40 per cent in volume terms) of the domestic organised market, followed by Kenstar (35 per cent), Bajaj Electricals (15 per cent) and Usha.


PB Jayakumar and Ajita Shashidhar
September 18, 2015
The re-positioning led by Tanya Dubash, according to A. Mahendran, former Managing Director of Godrej Consumer Products, not only resulted in robust revenue growth for the group but also helped it attract better talent.


PB Jayakumar
New Delhi, July 23, 2015
The acquisition enhances Lupin's scale in the US generic market and also broadens its pipeline in dermatology, controlled substance products and other high-value and niche generics.


PB Jayakumar
June 5, 2015
It is a fact that while drug regulators worldwide are steadily increasing regulatory standards, Indian companies are finding it difficult to keep pace with the changing higher benchmarks.


PB Jayakumar
June 3, 2015
About 30 per cent of survey respondents said they had experienced non-compliance with GxP guidelines (Good - x - Practice is based on guidelines for the pharmaceutical industry and covers all steps from drug development to production) in the last two years.


PB Jayakumar
May 28, 2015
Nestle confidently says there are no stated levels of MSG in India and since it does not add any artificial glutamate in Maggi, it is not bound to mention the chemical on the packets.


PB Jayakumar
May 22, 2015
About 20-30 per cent cases of infertility are related to 'secondary infertility' of the general infertility population, the study says.


PB Jayakumar
May 21, 2015
At present, sectors such as petro-chemicals, oil and gas, petroleum, mines and minerals, zinc, copper, lead-based production, textiles, asbestos, steel, tannery etc are classified under the Hazardous Waste (Management, Handling and Transboundary Movement) Rules 2008.


PB Jayakumar
May 19, 2015
Chilworth has already opened three offices in India at Mumbai, Hyderabad and Delhi, employing 35 process safety experts. It is planning to recruit more.


PB Jayakumar
May 5, 2015
Wockhardt Chairman Habil Khorakiwala speaks with P.B. Jayakumar about the company's recent decision to recall some drugs from the US and how the drug maker is trying to resolve issues related to the US FDA.


PB Jayakumar
May 16, 2015
For Daiichi, the exit from India is an opportunity lost in an industry where toplines are growing 15 per cent a year on average and margins are 15 to 20 per cent.


Rachit Goswami, PB Jayakumar
May 2, 2015
Murtaza Khorakiwala, managing director, Wockhardt, chalks out the steps taken by the company to ensure regulatory compliance, and business prospects from emerging and developed markets going ahead.


PB Jayakumar
April 29, 2015
The company will invest Rs 50-60 crore in two years for the expansion and is now talking to investors for raising funds for the expansion.


PB Jayakumar
April 21, 2015
Eight years after making its India foray through the acquisition of Ranbaxy Laboratories, Japan's second-largest drug company Daiichi Sankyo is leaving the Indian shores with lots of losses and bitter experiences.


PB Jayakumar
April 2, 2015
Unlike rural villagers who physically work hard on fields in an agrarian economy, urban Indians and Chinese lead a sedentary life without much exercise to burn the extra calories.


PB Jayakumar
March 26, 2015
Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries.


PB Jayakumar
March 25, 2015
Dilip Shanghvi, the founder and promoter of Sun Pharma, outlined the growth strategy of the merged entity-with a turnover of Rs 27,856 crore at a press conference in Mumbai.


PB Jayakumar
March 24, 2015
Aarti Drugs said on Tuesday that two of its facilities in Tarapur received an import alert on March 23 as per the FDA website.


PB Jayakumar
March 18, 2015
The acquisition, made by Intas' subsidiary Accord Healthcare, will help pharma company become the second-largest hospital business player in Spain.


PAGES 27 OF 28  262728